174 related articles for article (PubMed ID: 15485862)
21. The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activity.
Fischer F; Molinari M; Bodendorf U; Paganetti P
J Neurochem; 2002 Mar; 80(6):1079-88. PubMed ID: 11953458
[TBL] [Abstract][Full Text] [Related]
22. Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production.
Benjannet S; Elagoz A; Wickham L; Mamarbachi M; Munzer JS; Basak A; Lazure C; Cromlish JA; Sisodia S; Checler F; Chrétien M; Seidah NG
J Biol Chem; 2001 Apr; 276(14):10879-87. PubMed ID: 11152688
[TBL] [Abstract][Full Text] [Related]
23. Identification of phospholipid scramblase 1 as a novel interacting molecule with beta -secretase (beta -site amyloid precursor protein (APP) cleaving enzyme (BACE)).
Kametaka S; Shibata M; Moroe K; Kanamori S; Ohsawa Y; Waguri S; Sims PJ; Emoto K; Umeda M; Uchiyama Y
J Biol Chem; 2003 Apr; 278(17):15239-45. PubMed ID: 12586838
[TBL] [Abstract][Full Text] [Related]
24. Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression.
Liu K; Doms RW; Lee VM
Biochemistry; 2002 Mar; 41(9):3128-36. PubMed ID: 11863452
[TBL] [Abstract][Full Text] [Related]
25. Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid.
Bodendorf U; Danner S; Fischer F; Stefani M; Sturchler-Pierrat C; Wiederhold KH; Staufenbiel M; Paganetti P
J Neurochem; 2002 Mar; 80(5):799-806. PubMed ID: 11948243
[TBL] [Abstract][Full Text] [Related]
26. Endoproteolysis of beta-secretase (beta-site amyloid precursor protein-cleaving enzyme) within its catalytic domain. A potential mechanism for regulation.
Huse JT; Byant D; Yang Y; Pijak DS; D'Souza I; Lah JJ; Lee VM; Doms RW; Cook DG
J Biol Chem; 2003 May; 278(19):17141-9. PubMed ID: 12551920
[TBL] [Abstract][Full Text] [Related]
27. Amyloid precursor protein and BACE function as oligomers.
Multhaup G
Neurodegener Dis; 2006; 3(4-5):270-4. PubMed ID: 17047367
[TBL] [Abstract][Full Text] [Related]
28. The transmembrane domain of the Alzheimer's beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate.
Yan R; Han P; Miao H; Greengard P; Xu H
J Biol Chem; 2001 Sep; 276(39):36788-96. PubMed ID: 11466313
[TBL] [Abstract][Full Text] [Related]
29. Signal peptide peptidase forms a homodimer that is labeled by an active site-directed gamma-secretase inhibitor.
Nyborg AC; Kornilova AY; Jansen K; Ladd TB; Wolfe MS; Golde TE
J Biol Chem; 2004 Apr; 279(15):15153-60. PubMed ID: 14704149
[TBL] [Abstract][Full Text] [Related]
30. Identification of a beta-secretase activity, which truncates amyloid beta-peptide after its presenilin-dependent generation.
Fluhrer R; Multhaup G; Schlicksupp A; Okochi M; Takeda M; Lammich S; Willem M; Westmeyer G; Bode W; Walter J; Haass C
J Biol Chem; 2003 Feb; 278(8):5531-8. PubMed ID: 12471021
[TBL] [Abstract][Full Text] [Related]
31. Degradation of BACE by the ubiquitin-proteasome pathway.
Qing H; Zhou W; Christensen MA; Sun X; Tong Y; Song W
FASEB J; 2004 Oct; 18(13):1571-3. PubMed ID: 15289451
[TBL] [Abstract][Full Text] [Related]
32. gamma-secretase cleavage is distinct from endoplasmic reticulum degradation of the transmembrane domain of the amyloid precursor protein.
Bunnell WL; Pham HV; Glabe CG
J Biol Chem; 1998 Nov; 273(48):31947-55. PubMed ID: 9822665
[TBL] [Abstract][Full Text] [Related]
33. Crystallization of glycosylated human BACE protease domain expressed in Trichoplusia ni.
Wang W; Reichert P; Beyer BM; Liu JJ; Lee J; Zhang L; Liu YH; Taremi SS; Le HV; Strickland C
Biochim Biophys Acta; 2004 May; 1698(2):255-9. PubMed ID: 15134659
[TBL] [Abstract][Full Text] [Related]
34. Protein-protein interactions in the assembly and subcellular trafficking of the BACE (beta-site amyloid precursor protein-cleaving enzyme) complex of Alzheimer's disease.
Parsons RB; Austen BM
Biochem Soc Trans; 2007 Nov; 35(Pt 5):974-9. PubMed ID: 17956258
[TBL] [Abstract][Full Text] [Related]
35. Inhibiting β-secretase activity in Alzheimer's disease cell models with single-chain antibodies specifically targeting APP.
Boddapati S; Levites Y; Sierks MR
J Mol Biol; 2011 Jan; 405(2):436-47. PubMed ID: 21073877
[TBL] [Abstract][Full Text] [Related]
36. Large scale refolding and purification of the catalytic domain of human BACE-2 produced in E. coli.
Emmons TL; Mildner AM; Lull JM; Leone JW; Fischer HD; Heinrikson RL; Tomasselli AG
Protein Pept Lett; 2009; 16(2):121-31. PubMed ID: 19200034
[TBL] [Abstract][Full Text] [Related]
37. Evidence for dimeric BACE-mediated APP processing.
Jin S; Agerman K; Kolmodin K; Gustafsson E; Dahlqvist C; Jureus A; Liu G; Fälting J; Berg S; Lundkvist J; Lendahl U
Biochem Biophys Res Commun; 2010 Feb; 393(1):21-7. PubMed ID: 20097169
[TBL] [Abstract][Full Text] [Related]
38. An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.
Kornacker MG; Lai Z; Witmer M; Ma J; Hendrick J; Lee VG; Riexinger DJ; Mapelli C; Metzler W; Copeland RA
Biochemistry; 2005 Aug; 44(34):11567-73. PubMed ID: 16114893
[TBL] [Abstract][Full Text] [Related]
39. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.
Wiltfang J; Esselmann H; Cupers P; Neumann M; Kretzschmar H; Beyermann M; Schleuder D; Jahn H; Rüther E; Kornhuber J; Annaert W; De Strooper B; Saftig P
J Biol Chem; 2001 Nov; 276(46):42645-57. PubMed ID: 11526104
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of a novel membrane assay for full-length BACE-1 at pH 6.0.
Saric A; Brügge Lz; Müller-Pompalla D; Rysiok T; Ousson S; Permanne B; Quattropani A; Busch M; Beher D; Hussain I
J Biomol Screen; 2013 Mar; 18(3):277-85. PubMed ID: 23023105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
